erythrosine has been researched along with Learning Disabilities in 9 studies
Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.
Learning Disabilities: Conditions characterized by a significant discrepancy between an individual's perceived level of intellect and their ability to acquire new language and other cognitive skills. These may result from organic or psychological conditions. Relatively common subtypes include DYSLEXIA, DYSCALCULIA, and DYSGRAPHIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Atorvastatin treatment was neuroprotective against cell degeneration induced by Aβ(1-40), reducing inflammatory and oxidative responses and increasing the expression of glutamatergic transporters." | 1.36 | Atorvastatin prevents hippocampal cell death, neuroinflammation and oxidative stress following amyloid-β(1-40) administration in mice: evidence for dissociation between cognitive deficits and neuronal damage. ( Bezerra, SC; de Bem, AF; Duarte, FS; Figueiredo, CP; Mancini, G; Piermartiri, TC; Prediger, RD; Rial, D; Tasca, CI, 2010) |
| "Hyperglycemia has been shown to worsen the outcome of brain ischemia in several animal models but few experimental studies have investigated impairments in cognition induced by ischemic brain lesions in hyperglycemic animals." | 1.34 | Diabetic Goto-Kakizaki rats display pronounced hyperglycemia and longer-lasting cognitive impairments following ischemia induced by cortical compression. ( Cebers, G; Efendic, S; Liljequist, S; Moreira, T; Ostenson, CG; Pickering, C, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rehman, SU | 1 |
| Ahmad, A | 1 |
| Yoon, GH | 1 |
| Khan, M | 1 |
| Abid, MN | 1 |
| Kim, MO | 1 |
| Mehla, J | 1 |
| Lacoursiere, S | 1 |
| Stuart, E | 1 |
| McDonald, RJ | 1 |
| Mohajerani, MH | 1 |
| Naderali, E | 1 |
| Nikbakht, F | 1 |
| Ofogh, SN | 1 |
| Rasoolijazi, H | 1 |
| Akman, O | 1 |
| Moshé, SL | 1 |
| Galanopoulou, AS | 1 |
| Piermartiri, TC | 1 |
| Figueiredo, CP | 1 |
| Rial, D | 1 |
| Duarte, FS | 1 |
| Bezerra, SC | 1 |
| Mancini, G | 1 |
| de Bem, AF | 1 |
| Prediger, RD | 1 |
| Tasca, CI | 1 |
| Kassed, CA | 1 |
| Willing, AE | 1 |
| Garbuzova-Davis, S | 1 |
| Sanberg, PR | 1 |
| Pennypacker, KR | 1 |
| Pérez-Severiano, F | 1 |
| Salvatierra-Sánchez, R | 1 |
| Rodríguez-Pérez, M | 1 |
| Cuevas-Martínez, EY | 1 |
| Guevara, J | 1 |
| Limón, D | 1 |
| Maldonado, PD | 1 |
| Medina-Campos, ON | 1 |
| Pedraza-Chaverrí, J | 1 |
| Santamaría, A | 1 |
| Ballok, DA | 1 |
| Woulfe, J | 1 |
| Sur, M | 1 |
| Cyr, M | 1 |
| Sakic, B | 1 |
| Moreira, T | 1 |
| Cebers, G | 1 |
| Pickering, C | 1 |
| Ostenson, CG | 1 |
| Efendic, S | 1 |
| Liljequist, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effects of Early Atorvastatin Treatment During the Acute Phase of Stroke on Immunoinflammatory Markers and Outcome in Patients With Acute Ischemic Stroke Classified as LAAS According TOAST Classification[NCT02225834] | Phase 4 | 50 participants (Actual) | Interventional | 2011-11-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
9 other studies available for erythrosine and Learning Disabilities
| Article | Year |
|---|---|
Inhibition of c-Jun N-Terminal Kinase Protects Against Brain Damage and Improves Learning and Memory After Traumatic Brain Injury in Adult Mice.
Topics: Amyloid beta-Peptides; Animals; Anthracenes; Blood-Brain Barrier; Brain; Brain Edema; Brain Injuries | 2018 |
Gradual Cerebral Hypoperfusion Impairs Fear Conditioning and Object Recognition Learning and Memory in Mice: Potential Roles of Neurodegeneration and Cholinergic Dysfunction.
Topics: Animals; Brain; Carotid Stenosis; Cerebrovascular Circulation; Choline O-Acetyltransferase; Conditio | 2018 |
The role of rosemary extract in degeneration of hippocampal neurons induced by kainic acid in the rat: A behavioral and histochemical approach.
Topics: Animals; Avoidance Learning; Disease Models, Animal; Epilepsy, Temporal Lobe; Excitatory Amino Acid | 2018 |
Early life status epilepticus and stress have distinct and sex-specific effects on learning, subsequent seizure outcomes, including anticonvulsant response to phenobarbital.
Topics: Age Factors; Analysis of Variance; Animals; Animals, Newborn; Anticonvulsants; Convulsants; Disease | 2015 |
Atorvastatin prevents hippocampal cell death, neuroinflammation and oxidative stress following amyloid-β(1-40) administration in mice: evidence for dissociation between cognitive deficits and neuronal damage.
Topics: Amino Acid Transport System X-AG; Amyloid beta-Peptides; Analysis of Variance; Animals; Animals, New | 2010 |
Lack of NF-kappaB p50 exacerbates degeneration of hippocampal neurons after chemical exposure and impairs learning.
Topics: Animals; Behavior, Animal; Cell Death; Disease Models, Animal; Fluoresceins; Fluorescent Dyes; Hippo | 2002 |
S-Allylcysteine prevents amyloid-beta peptide-induced oxidative stress in rat hippocampus and ameliorates learning deficits.
Topics: Amyloid beta-Peptides; Animals; Cysteine; Drug Administration Schedule; Fluoresceins; Garlic; Glutat | 2004 |
Hippocampal damage in mouse and human forms of systemic autoimmune disease.
Topics: Aging; Animals; Choroid Plexus; Cyclophosphamide; Disease Models, Animal; fas Receptor; Female; Fluo | 2004 |
Diabetic Goto-Kakizaki rats display pronounced hyperglycemia and longer-lasting cognitive impairments following ischemia induced by cortical compression.
Topics: Animals; Blood Glucose; Brain Injuries; Brain Ischemia; Cognition Disorders; Conditioning, Operant; | 2007 |